TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
43 hedge funds and large institutions have $184M invested in Talis Biomedical Corporation Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.69M | |
| 2 | +$1.71M | |
| 3 | +$936K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$649K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$552K |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$5.21M | |
| 3 | -$3.21M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.89M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.29M |